Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Langmuir

• Publication date

  2009-04-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/la803973pPMID 19341292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles.

  2008cited by this paper
• A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum.

  2008cited by this paper
• Delivery Vehicles for Small Interfering RNA In Vivo

  2008cited by this paper
• Opportunities for treating chronic hepatitis B and C virus infection using RNA interference

  2007cited by this paper
• Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

  2007cited by this paper
• Lipid-based Nanoparticles for Nucleic Acid Delivery

  2007cited by this paper
• Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

  2007cited by this paper
• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

  2006cited by this paper
• New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

  2006cited by this paper
• RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

  2006cited by this paper
• siRNA-based approaches in cancer therapy

  2006cited by this paper
• RNAi-mediated gene silencing in non-human primates

  2006cited by this paper
• "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

  2006cited by this paper
• A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

  2006cited by this paper
• Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors.

  2005cited by this paper
• A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

  2005cited by this paper
• RNA interference as a new strategy against viral hepatitis.

  2004cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review

  2002cited by this paper
• Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.

  2001cited by this paper
• Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.

  2001cited by this paper
• Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo.

  1998cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

  1995cited by this paper

• Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview

  2025cites this paper
• Nanoliposomal quercetin reduces neuroinflammation and influences TLR4 and microglial activity with potential effects on GABAA2 receptors in a rat model of Huntington's disease.

  2025cites this paper
• Structuring of lipid nanoparticle mRNA formulations at acidic and neutral pH: X-ray scattering and molecular dynamics studies

  2025cites this paper
• Lipid nanoparticles driving mRNA vaccine innovations: From concept to clinic

  2025cites this paper
• Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.

  2024cites this paper
• Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design

  2023cites this paper
• Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out

  2023cites this paper
• A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement

  2022cites this paper
• Cell‐Derived Vesicles with Increased Stability and On‐Demand Functionality by Equipping Their Membrane with a Cross‐Linkable Copolymer

  2022cites this paper
• Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics

  2022cites this paper
• Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines.

  2021cites this paper
• Preparation of Drug Liposomes by Thin-Film Hydration and Homogenization

  2021cites this paper
• HER2-Specific PEGylated Immunoliposomes Prepared by Lyophilization/Rehydration Method

  2021cites this paper
• Strategies to deliver RNA by nanoparticles for therapeutic potential.

  2021cites this paper
• A review on liposome-based therapeutic approaches against malignant melanoma.

  2021cites this paper
• Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner.

  2020cites this paper
• MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles

  2020influential citation
• Intelligent TAT‐coupled anti‐HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma

  2019cites this paper
• State-of-the-Art Design and Rapid-Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery

  2018cites this paper
• Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid

  2017influential citation
• Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.

  2017cites this paper
• Erratum to: Anionic liposomes for small interfering ribonucleic acid (siRNA) delivery to primary neuronal cells: Evaluation of alpha-synuclein knockdown efficacy

  2017cites this paper
• Anionic liposomes for small interfering ribonucleic acid (siRNA) delivery to primary neuronal cells: Evaluation of alpha-synuclein knockdown efficacy

  2017cites this paper
• Inclusion of oligonucleotide antimicrobials in biocompatible cationic liposomes: A structural study.

  2017cites this paper
• Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

  2017cites this paper
• Using the interactions of designed siRNA and DNA drug carrier systems with human blood plasma and its components for controlled drug delivery

  2017cites this paper
• Exploring the intraperitoneal route of administration for siRNA delivery in the treatment of pertitoneal carcinomatosis

  2016cites this paper
• PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.

  2016cites this paper
• Effect of surface properties on liposomal siRNA delivery.

  2016cites this paper
• Exploring extracellular vesicles for siRNA delivery and Raman-based diagnostics

  2016cites this paper
• Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.

  2015cites this paper
• Disregarded Effect of Biological Fluids in siRNA Delivery: Human Ascites Fluid Severely Restricts Cellular Uptake of Nanoparticles.

  2015cites this paper
• Natural liposomes and synthetic polymeric structures for biomedical applications.

  2015cites this paper
• Designing of Tumor-Targeted HuR siRNA Nanoparticle as a Therapeutic for Lung Cancer

  2015cites this paper
• Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs.

  2015cites this paper
• Liposomes as siRNA delivery vectors.

  2015cites this paper
• Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy.

  2014cites this paper
• Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.

  2014cites this paper
• Gene Therapy Tools And Potential Applications

  2014cites this paper
• Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.

  2014cites this paper
• Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy.

  2014cites this paper
• Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA

  2014cites this paper
• Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing.

  2014cites this paper
• Non-Viral Delivery Systems in Gene Therapy

  2013cites this paper
• Lowering the sirna delivery barrier: Alginate scaffolds and immune stimulation

  2013cites this paper
• Ivo Edgar Araújo Lopes

  2013cites this paper
• Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.

  2013cites this paper
• Photosensitive nanocapsules for use in imaging from poly(styrene-co-divinylbenzene) cross-linked with coumarin derivatives.

  2013cites this paper
• Chapter 1 Non-Viral Delivery Systems in Gene Therapy

  2013cites this paper
• Development of Novel Ultra-Deformable Cationic Liposomes for siRNA Delivery to Fibrous Tumors

  2012cites this paper
• Development of dioctadecyldimethylammonium bromide/monoolein liposomes for gene delivery

  2012cites this paper
• Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design.

  2012cites this paper
• Cell-specific siRNA delivery by peptides and antibodies.

  2012cites this paper
• Action and reaction: the biological response to siRNA and its delivery vehicles.

  2012cites this paper
• The Pennsylvania State University The Graduate School Department of Bioengineering DEVELOPMENT OF NOVEL ULTRA-DEFORMABLE CATIONIC LIPOSOMES FOR siRNA DELIVERY TO FIBROUS TUMORS A Thesis in Bioengineering

  2012cites this paper
• Elucidation of gene function using RNA interference in a cancer cell culture model.

  2011cites this paper
• Nanocarriers: a tool to overcome biological barriers in siRNA delivery

  2011cites this paper
• The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes.

  2011cites this paper
• PEGylated calcium phosphate nano-carriers

  2011cites this paper
• Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.

  2010cites this paper
• Advanced fluorescence microscopy methods illuminate the transfection pathway of nucleic acid nanoparticles.

  2010cites this paper
• Pharmaceutical emulsions: a new approach for gene therapy

  2010cites this paper
• PEGylation of biodegradable dextran nanogels for siRNA delivery.

  2010cites this paper